Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Express Scripts
Mallinckrodt
McKesson
Moodys

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,806,256

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 6,806,256 protect, and when does it expire?

Patent 6,806,256 protects LEVAQUIN and is included in one NDA.

Protection for LEVAQUIN has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has seven patent family members in seven countries.

Summary for Patent: 6,806,256
Title: Taste masked liquid pharmaceutical compositions
Abstract:This invention is directed to a taste masked liquid pharmaceutical composition comprising a pharmaceutically active agent and a taste masking composition. In particular, the taste masking composition comprises a taste masking effective amount of an artificial sweetener.
Inventor(s): Ulrich; Stephen A. (Cherry Hill, NJ), Zimm; Karen R. (Stockton, NJ), Francois; Marc Karel Jozef (Kapellen, BE), Dries; Willy Maria Albert Carlo (Merksplas, BE)
Assignee: Ortho -McNeil Pharmaceutical, Inc. (Raritan, NJ)
Application Number:10/083,776
Patent Claim Types:
see list of patent claims
Composition; Formulation;

Drugs Protected by US Patent 6,806,256

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Janssen Pharms LEVAQUIN levofloxacin SOLUTION;ORAL 021721-001 Oct 21, 2004 DISCN Yes No   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,806,256

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Brazil 0207930   Start Trial
Canada 2440412   Start Trial
European Patent Office 1372662   Start Trial
Japan 2004535370   Start Trial
Mexico PA03008056   Start Trial
Malaysia 129406   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Baxter
Dow
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.